Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it has received the WindMade™ label, a global consumer label for companies that use wind energy and other renewable energy sources. BD received the WindMade™ label for the Company’s global operations, and certifies that 35% of […]
Paris, France, – Cellectis (Alternext: ALCLS), the Genome engineering specialist, has announced successfully programming cells from the immune system (T cells) to kill cancer cells. This technological breakthrough was revealed for the first time ever on Saturday, October 27th at the congress of the ESGCT (European Society of gene & Cell Therapy) in Versailles, outside […]
St. Louis, Mo. — Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the launch of a redesigned website for China, www.sigmaaldrich.com/china, which offers more relevant content, improved search results, enhanced product detail pages and a completely translated homepage. The Company also unveiled its new Vetec brand product line, providing the China market with an even broader portfolio […]
Malvern, UK: Materials characterization company Malvern Instruments Ltd. (Malvern, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern offers to the biopharmaceutical sector. The distribution agreement covers all geographies outside the USA and Canada. Under the terms of the agreement […]
BOTHELL, Wash., — BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced the Company’s novel biopreservation technology is being used in more than 50 clinical trial-stage cellular therapies, making it the leading […]
LANSING, Mich., — Neogen Corporation (Nasdaq: NEOG) has received Performance Tested MethodSM Certi? cation from the AOAC Research Institute for its new ANSR™ for Listeria assay, which is designed for rapid and de? nitive detection of Listeria. The issuance of this certi? cate, Number 101202 from the AOAC Research Institute, independently con? rms the performance […]
Rockland Immunochemicals Inc., a biotechnology company manufacturing antibodies and antibody-based tools for basic research, diagnostic assay development and preclinical studies is pleased to announce the expansion of a licensing and commercialization relationship with Lankenau Institute for Medical Research (LIMR) through its business development subsidiary LIMR Development, Inc. (LDI). Instrumental in advancing this relationship was Carl […]
AMSBIO has expanded its range of ready-to-use RNA samples to now include mRNA / microRNA tissue preparations and a large number of RNAs from mouse and rat development stages. With more than 20 years of experience in RNA isolation, AMSBIO has generated over 4000 individual total RNAs ready to go off-the-shelf, many with bioanalyser RIN […]
WALTHAM, Mass.– PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the third quarter ended September 30, 2012. The Company reported GAAP earnings per share from continuing operations of $0.25, compared to $0.25 in the third quarter of 2011. Revenue […]
GeneWorks Pty Ltd (Australia) introduces the Acquire PCR Cloning*. Acquire will be sold exclusively through Bulldog Bio in the USA. Ella Fontaine, V.P. of Communication at Bulldog Bio relates “The technology incorporated into the Acquire PCR Cloning Kit will provide our customers with the potential for extraordinary results from both A-tailed and blunt-ended PCR products, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
